Company news

Xilio Therapeutics, Inc. news in 2021

Xilio Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results

December 1, 2021

Xilio Therapeutics Announces Preclinical Data Demonstrating Anti-Tumor Activity and Tolerability of XTX301, a Tumor-Selective IL-12, at Society for Immunotherapy in Cancer Annual Meeting

November 11, 2021

Xilio Therapeutics Announces Closing of Initial Public Offering

October 25, 2021

Decks in 2021